Literature DB >> 12401663

An update of new targets for cancer treatment: receptor-mediated signals.

F Ciardiello1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401663     DOI: 10.1093/annonc/mdf635

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.

Authors:  Anju Preet; Zahida Qamri; Mohd W Nasser; Anil Prasad; Konstantin Shilo; Xianghong Zou; Jerome E Groopman; Ramesh K Ganju
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-19

2.  Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer.

Authors:  M Fakih; M Vincent
Journal:  Curr Oncol       Date:  2010-07       Impact factor: 3.677

3.  Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status.

Authors:  Nagla Abdel Karim; Salma Musaad; Ahmad Zarzour; Sadanand Patil; Abdul Rahman Jazieh
Journal:  Clin Med Insights Oncol       Date:  2014-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.